[Beta receptor blockers in migraine].
Soyka
D
D
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D002936:Cinnarizine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004087:Dihydroergotamine / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005444:Flunarizine; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008881:Migraine Disorders / Q000188:drug therapy*; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D014151:Anti-Anxiety Agents; D002936:Cinnarizine; D004087:Dihydroergotamine; D005444:Flunarizine
Beta-Rezeptorenblocker bei Migräne.